Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 154 of 1,261

  1. US 11833160

    Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases

    UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  2. US 11834441

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  3. US 11833221

    Oligomeric compounds for reducing DMPK expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  4. US 11834462

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  5. US 11833217

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11834507

    Anti-MET agonist antibody for use in the treatment of colorectal cancer

    AGOMAB THERAPEUTICS · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  7. US 2023381101

    AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Nov 30, 2023 · Expires Nov 25, 2043

    granted

  8. US 11827616

    Heterocyclic compounds as pesticides

    Discovery Purchaser Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  9. US 11825819

    Crnn loss of function rodent model

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  10. US 11827883

    Dosages and methods for delivering lipid formulated nucleic acid molecules

    Alnylam Pharmaceuticals, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  11. US 11826321

    Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

    TONIX PHARMA LIMITED · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  12. US 11826327

    Treatment for interstitial lung disease

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  13. US 11826322

    Pre-filled syringe

    Teva Pharmaceuticals USA, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  14. US 11826325

    Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection

    The First Affiliated Hospital of Xi'an Jiaotong University · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  15. US 11826328

    Stable treprostinil prodrugs

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  16. US 11826373

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  17. US 11827683

    Bi-functional anti-tau polypeptides and use thereof

    REGENERATIVE RESEARCH FOUNDATION · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  18. US 11826370

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  19. US 11826354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  20. US 11826405

    Neurotoxin compositions for use in treating headache

    Aeon Biopharma, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  21. US 11826408

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  22. US 11826422

    Methods and compositions for adaptive immune modulation

    The Board of Regents of the University of Texas System · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  23. US 11826415

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  24. US 11826469

    Polymer particles for neutrophil injury

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.